Jiangsu Bide Science and Technology Co.,Ltd. (SHA:605298)
China · Delayed Price · Currency is CNY 58.67
-0.53 (-0.90%)
Apr 30, 2026, 3:00 PM CST
SHA:605298 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 552.64 | 469.73 | 346.56 | 228.67 | 298.31 |
Other Revenue | 8.82 | 13.31 | 1.63 | 0.87 | 2.4 |
| 561.47 | 483.04 | 348.19 | 229.54 | 300.7 | |
Revenue Growth (YoY) | 16.24% | 38.73% | 51.69% | -23.66% | -13.47% |
Cost of Revenue | 326.86 | 291.58 | 218.87 | 112.7 | 139.26 |
Gross Profit | 234.61 | 191.46 | 129.32 | 116.84 | 161.45 |
Selling, General & Admin | 103.32 | 105.94 | 73.77 | 50.25 | 48.57 |
Research & Development | 29.1 | 25.49 | 26.91 | 22.6 | 22.9 |
Other Operating Expenses | 4.93 | 4.97 | 1.26 | 1.55 | 2.37 |
Operating Expenses | 137.69 | 141.45 | 109.01 | 81.02 | 76.6 |
Operating Income | 96.91 | 50.01 | 20.31 | 35.82 | 84.84 |
Interest Expense | -0.51 | -1.42 | -0.85 | -0.47 | -0.09 |
Interest & Investment Income | 2.23 | 4.99 | 11.16 | 11.45 | 12.16 |
Currency Exchange Gain (Loss) | -0 | 0 | -0 | 0 | -0 |
Other Non Operating Income (Expenses) | -0.15 | -0.1 | -0.07 | 0.04 | -0.05 |
EBT Excluding Unusual Items | 98.48 | 53.48 | 30.55 | 46.84 | 96.86 |
Impairment of Goodwill | -22.63 | -1.92 | - | - | - |
Gain (Loss) on Sale of Investments | -0.25 | -0.54 | -0.09 | - | - |
Gain (Loss) on Sale of Assets | 0.43 | 0.31 | - | 0.21 | - |
Asset Writedown | - | -0.11 | -0.1 | -0.02 | -0.05 |
Other Unusual Items | -2.39 | -2.18 | 7.36 | 6.08 | 0.51 |
Pretax Income | 73.65 | 49.05 | 37.72 | 53.1 | 97.33 |
Income Tax Expense | 15.32 | 10.69 | 7.48 | 6.58 | 12.42 |
Earnings From Continuing Operations | 58.33 | 38.36 | 30.24 | 46.53 | 84.91 |
Minority Interest in Earnings | -1.55 | 0.5 | 0.39 | 0.3 | -0.38 |
Net Income | 56.78 | 38.86 | 30.63 | 46.82 | 84.53 |
Net Income to Common | 56.78 | 38.86 | 30.63 | 46.82 | 84.53 |
Net Income Growth | 46.13% | 26.86% | -34.59% | -44.60% | -19.11% |
Shares Outstanding (Basic) | 183 | 185 | 146 | 184 | 177 |
Shares Outstanding (Diluted) | 183 | 185 | 146 | 184 | 177 |
Shares Change (YoY) | -1.01% | 26.86% | -20.95% | 4.09% | 29.47% |
EPS (Basic) | 0.31 | 0.21 | 0.21 | 0.25 | 0.48 |
EPS (Diluted) | 0.31 | 0.21 | 0.21 | 0.25 | 0.48 |
EPS Growth | 47.62% | - | -17.26% | -46.78% | -37.52% |
Free Cash Flow | 134.91 | -100.68 | -71.41 | -22.29 | 24.91 |
Free Cash Flow Per Share | 0.74 | -0.54 | -0.49 | -0.12 | 0.14 |
Dividend Per Share | 0.200 | 0.150 | 0.100 | 0.115 | 0.237 |
Dividend Growth | 33.33% | 50.00% | -13.35% | -51.25% | - |
Gross Margin | 41.78% | 39.64% | 37.14% | 50.90% | 53.69% |
Operating Margin | 17.26% | 10.35% | 5.83% | 15.60% | 28.21% |
Profit Margin | 10.11% | 8.04% | 8.80% | 20.40% | 28.11% |
Free Cash Flow Margin | 24.03% | -20.84% | -20.51% | -9.71% | 8.28% |
EBITDA | 120.66 | 71.44 | 31.17 | 43.96 | 92.08 |
EBITDA Margin | 21.49% | 14.79% | 8.95% | 19.15% | 30.62% |
D&A For EBITDA | 23.75 | 21.43 | 10.86 | 8.15 | 7.24 |
EBIT | 96.91 | 50.01 | 20.31 | 35.82 | 84.84 |
EBIT Margin | 17.26% | 10.35% | 5.83% | 15.60% | 28.21% |
Effective Tax Rate | 20.80% | 21.79% | 19.84% | 12.38% | 12.76% |
Revenue as Reported | 561.47 | 483.04 | 348.19 | 229.54 | 300.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.